Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Lifevantage (LFVN) over the last 15 years, with Q4 2025 value amounting to $2.3 million.

  • Lifevantage's Receivables - Net rose 809.77% to $2.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 million, marking a year-over-year increase of 809.77%. This contributed to the annual value of $3.3 million for FY2025, which is 1169.89% up from last year.
  • According to the latest figures from Q4 2025, Lifevantage's Receivables - Net is $2.3 million, which was up 809.77% from $2.4 million recorded in Q3 2025.
  • Over the past 5 years, Lifevantage's Receivables - Net peaked at $3.3 million during Q2 2022, and registered a low of $1.6 million during Q2 2023.
  • For the 5-year period, Lifevantage's Receivables - Net averaged around $2.6 million, with its median value being $2.5 million (2023).
  • As far as peak fluctuations go, Lifevantage's Receivables - Net surged by 18410.65% in 2021, and later plummeted by 5170.76% in 2023.
  • Over the past 5 years, Lifevantage's Receivables - Net (Quarter) stood at $2.4 million in 2021, then fell by 0.41% to $2.4 million in 2022, then decreased by 2.99% to $2.3 million in 2023, then fell by 10.62% to $2.1 million in 2024, then increased by 8.1% to $2.3 million in 2025.
  • Its Receivables - Net stands at $2.3 million for Q4 2025, versus $2.4 million for Q3 2025 and $3.3 million for Q2 2025.